Literature DB >> 14961791

Value of tissue Doppler imaging to predict left ventricular filling pressure in patients with coronary artery disease.

Nicolas Mansencal1, Erik Bouvier, Thierry Joseph, Jean-Christian Farcot, Rémi Pillière, Alban Redheuil, Pascal Lacombe, Guillaume Jondeau, Olivier Dubourg.   

Abstract

Assessment of left ventricular (LV) diastolic filling pressure provides important information on the hemodynamic status in the general population. The aim of our study was to investigate the reliability of tissue Doppler imaging (TDI) in estimating left ventricular filling pressure in patients with coronary artery disease (CAD). We prospectively studied 32 consecutive CAD-patients, mean age 64 +/- 12 years, in sinus rhythm. All patients underwent cardiac catheterization and echocardiography within the same hour. Catheterization investigated pre-A-wave pressure (preA) and LV ejection fraction (LVEF). Echocardiographic LVEF was calculated using wall motion indexes (WMI) with segmental division of LV wall. The following Doppler parameters were assessed: (1) PW Doppler signals from the mitral inflow (E), (2) PW TDI of the mitral annulus (E'), thus allowing to obtain the mitral inflow to annulus ratio (E/E'). The best correlation between invasive and echocardiographic LVEF was observed using WMI (r = 0.91). The correlations between preA and E, E', and E/E' were significant (r = 0.36, r = 0.38, and r = 0.60, respectively). In patients with LVEF >50%, no correlation between E/E' and preA was found (r = 0.18, P = 0.44), whereas with LVEF <50%, this correlation was strong (r = 0.76, P < 0.001). In patients with myocardial infarction, the correlation between E/E' and preA was significant whatever the localization of myocardial infarction (r > 0.71, P < 0.05). ROC curve analysis identified an E/E'>9 to be the best cut-off value related to preA > 15 mmHg. We conclude that the mitral inflow-to-annulus ratio is a reliable method in CAD patients and allows determination of LV filling pressure when LVEF <50%.

Entities:  

Mesh:

Year:  2004        PMID: 14961791     DOI: 10.1111/j.0742-2822.2004.03045.x

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  6 in total

1.  Is E/E' reliable in patients with regional wall motion abnormalities to estimate left ventricular filling pressure?

Authors:  Hong-Seok Lim; Soo-Jin Kang; Jung-Hyun Choi; Sung-Gyun Ahn; Byoung-Joo Choi; So-Yeon Choi; Myeong-Ho Yoon; Gyo-Seung Hwang; Seung-Jea Tahk; Joon-Han Shin
Journal:  Int J Cardiovasc Imaging       Date:  2008-07-18       Impact factor: 2.357

Review 2.  The Role of Echocardiography in Heart Failure with Preserved Ejection Fraction: What Do We Want from Imaging?

Authors:  Masaru Obokata; Yogesh N V Reddy; Barry A Borlaug
Journal:  Heart Fail Clin       Date:  2019-02-02       Impact factor: 3.179

3.  Are normative values for LV geometry and mass based on fundamental imaging valid with use of harmonic imaging?

Authors:  Lisa de Las Fuentes; Karen E Spence; Victor G Dávila-Román; Alan D Waggoner
Journal:  J Am Soc Echocardiogr       Date:  2010-09-21       Impact factor: 5.251

4.  Assessment of ventricular functions by tissue Doppler echocardiography in children with asthma.

Authors:  Osman Ozdemir; Yasemin Ceylan; Cem Hasan Razi; Ozben Ceylan; Nesibe Andiran
Journal:  Pediatr Cardiol       Date:  2012-09-11       Impact factor: 1.655

5.  Non-invasive assessment of coronary artery stenosis with estimation of myocardial wall stress.

Authors:  Hassan Moladoust; Manijhe Mokhtari-Dizaji; Zahra Ojaghi-Haghighi; Fereidoon Noohi
Journal:  J Tehran Heart Cent       Date:  2010-02-28

Review 6.  Diagnostic Accuracy of Tissue Doppler Index E/e' for Evaluating Left Ventricular Filling Pressure and Diastolic Dysfunction/Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis.

Authors:  Oleg F Sharifov; Chun G Schiros; Inmaculada Aban; Thomas S Denney; Himanshu Gupta
Journal:  J Am Heart Assoc       Date:  2016-01-25       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.